Eltabbakh Gamal H, Mount Sharon L
Lake Champlain Gynecologic Oncology, 364 Dorset Street, South Burlington, VT 05403, USA.
Gynecol Oncol. 2006 Feb;100(2):361-4. doi: 10.1016/j.ygyno.2005.08.040. Epub 2005 Sep 26.
The purpose of our study was to find if uterine manipulation at the time of laparoscopic hysterectomy among women with endometrial carcinoma increases the incidence of malignant cells in the peritoneal washings.
We conducted a prospective study including women with clinical stage I endometrioid endometrial carcinoma undergoing laparoscopic surgery between 07/01/2000 and 07/01/2004. Surgery on all patients was conducted by the same surgeon using the same technique and instruments. Two sets of peritoneal washings were obtained, one before and one after the insertion of the Pelosi uterine manipulator. The two sets of washings were blindly reviewed by the same cytopathologist for the presence of malignant cells. Correlation was made between the two sets of washings.
Forty-two consecutive women (age 46-90, median: 58) were enrolled in the study. The procedure was converted to laparotomy in 3 (7.6%) patients after obtaining the two sets of washings. The preoperative tumor grades were: G1: 22 (52.4%), G2: 12 (28.6%), and G3: 8 (19.0). The incidence of positive peritoneal washings was 14.3%. All patients underwent laparoscopically assisted vaginal hysterectomy with bilateral salpingo-oophorectomy, 30 patients had bilateral pelvic lymphadenectomy, and 5 patients had bilateral pelvic and para-aortic lymphadenectomy. There was perfect agreement between the two sets of washings in all patients (100%, P < .001). No patients had positive washings after the insertion of the uterine manipulator if the washings were negative before the insertion. The surgical stages were: IA: 14 (33.3%), IB: 12 (28.6%), IC: 7 (16.7%), IIA: 1 (2.4%), IIB: 1 (2.4%), IIIA: 4 (9.5%), IIIB: 1 (2.4%), IIIC: 1 (2.4%), and IV: 1 (2.4%). Twenty-nine patients received no postoperative treatment, 2 received chemotherapy, 3 received Megace, and 9 received radiation therapy. Patients were followed-up for 7-56 months (median: 28). Two patients had tumor recurrence, and one patient died secondary to her disease. Two other patients died secondary to other causes.
We conclude that uterine manipulation at the time of laparoscopic hysterectomy does not increase the incidence of positive peritoneal cytology among women with endometrial carcinoma.
我们研究的目的是确定子宫内膜癌女性在腹腔镜子宫切除术中进行子宫操作是否会增加腹腔冲洗液中恶性细胞的发生率。
我们进行了一项前瞻性研究,纳入了2000年7月1日至2004年7月1日期间接受腹腔镜手术的临床I期子宫内膜样腺癌女性。所有患者均由同一位外科医生使用相同技术和器械进行手术。获取两组腹腔冲洗液,一组在插入佩洛西子宫操纵器之前,另一组在之后。同一位细胞病理学家对两组冲洗液进行盲法检查,以确定是否存在恶性细胞。对两组冲洗液进行相关性分析。
42例连续女性(年龄46 - 90岁,中位数:58岁)纳入研究。在获取两组冲洗液后,3例(7.6%)患者手术转为开腹。术前肿瘤分级为:G1:22例(52.4%),G2:12例(28.6%),G3:8例(19.0%)。腹腔冲洗液阳性发生率为14.3%。所有患者均接受腹腔镜辅助阴道子宫切除术及双侧输卵管卵巢切除术,30例患者接受双侧盆腔淋巴结清扫术,5例患者接受双侧盆腔及腹主动脉旁淋巴结清扫术。所有患者两组冲洗液结果完全一致(100%,P <.001)。如果插入子宫操纵器前冲洗液为阴性,则插入后无患者冲洗液呈阳性。手术分期为:IA:14例(33.3%),IB:12例(28.6%),IC:7例(16.7%),IIA:1例(2.4%),IIB:1例(2.4%),IIIA:4例(9.5%),IIIB:1例(2.4%),IIIC:1例(2.4%),IV:1例(2.4%)。29例患者未接受术后治疗,2例接受化疗,3例接受甲地孕酮,9例接受放疗。患者随访7 - 56个月(中位数:28个月)。2例患者出现肿瘤复发,1例患者因疾病死亡。另外2例患者因其他原因死亡。
我们得出结论,子宫内膜癌女性在腹腔镜子宫切除术中进行子宫操作不会增加腹腔细胞学检查阳性的发生率。